Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Reads0
Chats0
TLDR
Cell populations of the monocyte-macrophage lineage, which originate in the bone marrow, are of particular importance in HIV-1 persistence due to their ability to cross the blood-brain barrier and spread HIV- 1 infection in the immunoprivileged central nervous system (CNS).Abstract:
A major obstacle in human immunodeficiency virus type 1 (HIV-1) eradication is the ability of the virus to remain latent in a subpopulation of the cells it infects. Latently infected cells can escape the viral immune response and persist for long periods of time, despite the presence of successful highly active antiretroviral therapy (HAART). Given the appropriate stimulus, latently infected cells can reactivate and start producing infectious virions. The susceptibility of these cell populations to HIV-1, their life span, their proliferative capacity, and their ability to periodically produce infectious virus subsequent to alterations in cellular physiology and/or immunologic controls are critical issues which determine the contribution of these cells to viral persistence. Memory CD4+ T cells due to the long life span, which may be several years, and their ability to reactivate upon encounter with their cognate antigen or other stimulation, are considered a critical reservoir for maintenance of latent HIV-1 proviral DNA. Cells of the monocyte-macrophage lineage, which originate in the bone marrow (BM), are of particular importance in HIV-1 persistence due to their ability to cross the blood-brain barrier (BBB) and spread HIV-1 infection in the immunoprivileged central nervous system (CNS). Hematopoietic progenitor cells (HPCs) are also a potential HIV-1 reservoir, as several studies have shown that CD34+ HPCs carrying proviral DNA can be found in vivo in a subpopulation of HIV-1-infected patients. The ability of HPCs to proliferate and potentially generate clonal populations of infected cells of the monocyte-macrophage lineage may be crucial in HIV-1 dissemination. The contribution of these and other cell populations in HIV-1 persistence, as well as the possible strategies to eliminate latently infected cells are critically examined in this review.read more
Citations
More filters
Journal ArticleDOI
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
Steven A. Yukl,Eli Boritz,Michael P. Busch,Christopher Bentsen,Tae Wook Chun,Daniel C. Douek,Evelyn E. Eisele,Ashley T. Haase,Ya Chi Ho,Gero Hütter,J. Shawn Justement,Sheila M. Keating,Tzong-Hae Lee,Peilin Li,Danielle Murray,Sarah Palmer,Christopher D. Pilcher,Satish K. Pillai,Richard W. Price,Meghan K Rothenberger,Timothy W. Schacker,Janet M. Siliciano,Robert F. Siliciano,Robert F. Siliciano,Elizabeth Sinclair,Matthew C. Strain,Joseph K. Wong,Douglas D. Richman,Steven G. Deeks +28 more
TL;DR: The absence of recrudescent HIV replication and waning HIV-specific immune responses five years after withdrawal of treatment provide proof of a clinical cure.
Journal ArticleDOI
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
TL;DR: It is proposed that interaction of HIV-1 with macrophages is crucial during all stages of HIV -1 infection, the development of acquired immunodeficiency syndrome (AIDS) and HIV-associated diseases, including neurocognitive disorders.
Journal ArticleDOI
Illuminating viral infections in the nervous system
TL;DR: This Review focuses on the strategies used by neurotropic viruses to cross the barrier systems of the CNS and on how the immune system detects and responds to viral infections in the CNS.
Journal ArticleDOI
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Christopher M. Coleman,Li-Li Wu +1 more
TL;DR: This review updates the latest advances in the study of HIV interactions with monocytes and dendritic cells, and highlights the potential role of these cells as viral reservoirs and the effects of the HIV-host-cell interactions on viral pathogenesis.
Journal ArticleDOI
HIV virology and pathogenetic mechanisms of infection: a brief overview
TL;DR: The characteristics of molecular structure, replication and pathogenesis of HIV are reviewed, with a particular focus on those aspects that are important for the design of diagnostic assays.
References
More filters
Journal ArticleDOI
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.
Andrew J. Bannister,Philip Zegerman,Janet F. Partridge,Eric A. Miska,Jean O. Thomas,Robin C. Allshire,Tony Kouzarides +6 more
TL;DR: A stepwise model for the formation of a transcriptionally silent heterochromatin is provided: SUV39H1 places a ‘methyl marker’ on histone H3, which is then recognized by HP1 through its chromo domain, which may also explain the stable inheritance of theheterochromatic state.
Journal ArticleDOI
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Teunis B.H. Geijtenbeek,Douglas S. Kwon,Ruurd Torensma,S.J. van Vliet,G.C.F. van Duijnhoven,J. Middel,I.L.M.H.A. Cornelissen,H.S.L.M. Nottet,Vineet N. KewalRamani,Dan R. Littman,Carl G. Figdor,Y. van Kooyk +11 more
TL;DR: It is proposed that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.
Journal ArticleDOI
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Tae Wook Chun,Lucy M. Carruth,Diana Finzi,Xuefei Shen,Joseph A. DiGiuseppe,Harry E. Taylor,Monika Hermankova,Karen Chadwick,Joseph B. Margolick,Thomas C. Quinn,Thomas C. Quinn,Yen Hong Kuo,Ron Brookmeyer,Martha A. Zeiger,Patricia Barditch-Crovo,Robert F. Siliciano +15 more
TL;DR: It is shown that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated pro virus (<107 cells).
Journal ArticleDOI
Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Diana Finzi,Joel N. Blankson,Janet M. Siliciano,Joseph B. Margolick,Karen Chadwick,Theodore C. Pierson,Kendall A. Smith,Julianna Lisziewicz,Franco Lori,Charles Flexner,Thomas C. Quinn,Richard E. Chaisson,Eric S. Rosenberg,Bruce D. Walker,Stephen J. Gange,Joel E. Gallant,Robert F. Siliciano +16 more
TL;DR: The mean half-life of the latent reservoir was very long (43.9 months) and the decay rate of this latent reservoir in 34 treated adults whose plasma virus levels were undetectable as mentioned in this paper.
Journal ArticleDOI
Decay characteristics of HIV-1-infected compartments during combination therapy
Alan S. Perelson,Paulina Essunger,Yunzhen Cao,Mika Vesanen,Arlene Hurley,Kalle Saksela,Martin Markowitz,David D. Ho +7 more
TL;DR: It is estimated that 2.3–3.1 years of a completely inhibitory treatment would be required to eliminate HIV-1 from these compartments, and even longer treatment may be needed because of the possible existence of undetected viral compartments or sanctuary sites.
Related Papers (5)
Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont,Mohamed El-Far,Petronela Ancuta,Lydie Trautmann,Francesco A. Procopio,Bader Yassine-Diab,Geneviève Boucher,Mohamed Rachid Boulassel,Georges Ghattas,Jason M. Brenchley,Timothy W. Schacker,Brenna J. Hill,Daniel C. Douek,Jean-Pierre Routy,Elias K. Haddad,Elias K. Haddad,Rafick Pierre Sekaly +16 more